Previous Article | Next Article ![]()
J Virol, June 1998, p. 5271-5275, Vol. 72, No. 6
Departments of Medicine, Pathology, and
Molecular Microbiology, Washington University School of Medicine,
St. Louis, Missouri 63110
Received 12 August 1996/Accepted 9 February 1998
Incorporation of Vpx into human immunodeficiency virus type 2 (HIV-2) virus-like particles is mediated by the Gag polyprotein. We
have identified residues 15 to 40 of Gag p6 and residues 73 to 89 of
Vpx as being necessary for virion incorporation. In addition, we show
enhanced in vitro binding of Vpx to a chimeric HIV-1/HIV-2 Gag
construct containing residues 2 to 49 of HIV-2 p6 and demonstrate that
the presence of residues 73 to 89 of Vpx allows for in vitro binding to
HIV-2 Gag.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 2 Vpx-Gag
Interaction
*
Corresponding author. Mailing address: Box 8069, 660 S. Euclid, Washington University School of Medicine, St. Louis, MO 63110. Phone: (314) 362-8836. Fax: (314) 454-1792. E-mail:
lratner{at}imgate.wustl.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»